Wednesday, June 10, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “modified”

433 pharma patents match "modified" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 433
Index total 30,257
Page 15 / 19

Quick answer

This filtered view shows 433 pharmaceutical patents matching "modified" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

433 results for “modified” · 30,257 patents in full index Clear search

  1. US 8048990

    Modified vitamin K-dependent polypeptides

    Regents of the University of Minnesota · Granted Nov 1, 2011 · Expires Oct 27, 2031

    granted

  2. US 8034825

    Chemically modified small molecules

    Nektar Therapeutics · Granted Oct 11, 2011 · Expires Oct 6, 2031

    granted

  3. US 8029791

    Modified chimeric polypeptides with improved pharmacokinetic properties

    REGENERON PHARMACEUTICALS, INC. · Granted Oct 4, 2011 · Expires Sep 29, 2031

    granted

  4. US 8021687

    Modified release compositions of milnacipran

    Collegium Pharmaceutical, Inc. · Granted Sep 20, 2011 · Expires Sep 15, 2031

    granted

  5. US 8017763

    Chemically modified oligonucleotides

    Alnylam Pharmaceuticals, Inc. · Granted Sep 13, 2011 · Expires Sep 8, 2031

    granted

  6. US 8017762

    Modified iRNA agents

    Alnylam Pharmaceuticals, Inc. · Granted Sep 13, 2011 · Expires Sep 8, 2031

    granted

  7. US 8017149

    Modified release preparations containing oxcarbazepine and derivatives thereof

    Supernus Pharmaceuticals, Inc. · Granted Sep 13, 2011 · Expires Sep 8, 2031

    granted

  8. US 7988977

    Modified live Aeromonas hydrophila vaccine for aquatic animals

    The United States of America, as represented by the Secretary of Agriculture · Granted Aug 2, 2011 · Expires Jul 28, 2031

    granted

  9. US 7910131

    Method of treating seizures using modified release formulations of oxcarbazepine

    Supernus Pharmaceuticals, Inc. · Granted Mar 22, 2011 · Expires Mar 17, 2031

    granted

  10. US 7893224

    Oligonucleotides comprising a ligand tethered to a modified or non-natural nucleobase

    Alnylam Pharmaceuticals, Inc. · Granted Feb 22, 2011 · Expires Feb 17, 2031

    granted

  11. US 7888070

    Nucleic acids encoding growth hormone with a modified RSP sorting signal

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Feb 15, 2011 · Expires Feb 10, 2031

    granted

  12. US 7812132

    Modified vitamin K-dependent polypeptides

    Regents of the University of Minnesota · Granted Oct 12, 2010 · Expires Oct 7, 2030

    granted

  13. US 7807179

    Modified reoviral therapy

    The Board of Regents of the University of Texas System · Granted Oct 5, 2010 · Expires Sep 30, 2030

    granted

  14. US 7803385

    Reoviruses having modified sequences

    ONCOLYTICS BIOTECH INC. · Granted Sep 28, 2010 · Expires Sep 23, 2030

    granted

  15. US 7786133

    Chemically modified small molecules

    Nektar Therapeutics · Granted Aug 31, 2010 · Expires Aug 26, 2030

    granted

  16. US 7772387

    Oligonucleotides comprising a modified or non-natural nucleobase

    Alnylam Pharmaceuticals, Inc. · Granted Aug 10, 2010 · Expires Aug 5, 2030

    granted

  17. US 7750120

    Modified vitamin K-dependent polypeptides

    Regents of the University of Minnesota · Granted Jul 6, 2010 · Expires Jul 1, 2030

    granted

  18. US 7745691

    Genetically modified mouse lacking diacylglycerol acyltransferase-1 (DGAT-1) activity

    The Regents of the University of California · Granted Jun 29, 2010 · Expires Jun 24, 2030

    granted

  19. US 7745608

    Modified iRNA agents

    Alnylam Pharmaceuticals, Inc. · Granted Jun 29, 2010 · Expires Jun 24, 2030

    granted

  20. US 7722898

    Modified-release preparations containing oxcarbazepine and derivatives thereof

    Supernus Pharmaceuticals, Inc. · Granted May 25, 2010 · Expires May 20, 2030

    granted

  21. US 7704500

    Methods of inhibiting ascites formation with modified chimeric VEGF polypeptides

    REGENERON PHARMACEUTICALS, INC. · Granted Apr 27, 2010 · Expires Apr 22, 2030

    granted

  22. US 7704527

    Modified release compositions of milnacipran

    Collegium Pharmaceutical, Inc. · Granted Apr 27, 2010 · Expires Apr 22, 2030

    granted

  23. US 7674778

    Oligonucleotides comprising a conjugate group linked through a C5-modified pyrimidine

    Alnylam Pharmaceuticals, Inc. · Granted Mar 9, 2010 · Expires Mar 4, 2030

    granted

  24. US 7662923

    Modified vitamin K-dependent polypeptides

    Regents of the University of Minnesota · Granted Feb 16, 2010 · Expires Feb 11, 2030

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.